HIGH DOSE INTERLEUKIN-2 (IL-2) THERAPY IN "LYMPHODEPLETED PRIMED" PATIENTS WITH

这个子项目是众多研究子项目之一

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This a Phase II study of lymphodepletion using cyclophosphamide and fludarabine combined with high dose Interleukin-2 (IL-2) and GM-CSF in patients with metastitic melanoma.